These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6695633)
1. One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease. Diamond SG; Markham CH Adv Neurol; 1984; 40():537-9. PubMed ID: 6695633 [No Abstract] [Full Text] [Related]
2. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604 [TBL] [Abstract][Full Text] [Related]
3. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease. Olanow CW; Alberts MJ Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266 [No Abstract] [Full Text] [Related]
5. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial. Gilligan B; Wodak J; Stark R; O'Halloran M Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336 [TBL] [Abstract][Full Text] [Related]
6. Sinemet in Parkinson's disease: efficacy with and without food. Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604 [No Abstract] [Full Text] [Related]
7. Further studies with pergolide in Parkinson disease. Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E; Nelson J Neurology; 1982 Oct; 32(10):1181-4. PubMed ID: 6889703 [TBL] [Abstract][Full Text] [Related]
8. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Klawans HL; Tanner CM; Glatt S; Goetz CG Adv Neurol; 1983; 37():75-83. PubMed ID: 6344592 [No Abstract] [Full Text] [Related]
9. Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Pasternack P N Y State J Med; 1986 Dec; 86(12):655-6. PubMed ID: 3468386 [No Abstract] [Full Text] [Related]
10. [Combined therapy of carbidopa and levodopa in Parkinson's disease]. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):201-4. PubMed ID: 4075908 [No Abstract] [Full Text] [Related]
11. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease]. Bermejo Pareja F; Martínez-Martín P Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135 [No Abstract] [Full Text] [Related]
12. Response to Sinemet 25/100 in Parkinson's disease. Ulm G; Gerdes U; Lehmann K Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634 [No Abstract] [Full Text] [Related]
13. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Goetz CG; Tanner CM; Klawans HL; Shannon KM; Carroll VS Neurology; 1987 May; 37(5):875-8. PubMed ID: 3574696 [TBL] [Abstract][Full Text] [Related]
14. Pergolide in late-stage Parkinson disease. Lang AE; Quinn N; Brincat S; Marsden CD; Parkes JD Ann Neurol; 1982 Sep; 12(3):243-7. PubMed ID: 6753730 [TBL] [Abstract][Full Text] [Related]
15. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
18. Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease. Lieberman AN; Goldstein M; Leibowitz M N Y State J Med; 1988 Aug; 88(8):420-2. PubMed ID: 2902541 [No Abstract] [Full Text] [Related]